| 2025 | P/S | Medicinal preparations and substances; Pharmaceutical preparations and substances; Pharmaceutical... | 
				    			
				    				
				    					|  | Invention | Process for the steroselective preparation of chiral 2-[(hetero)arylalkylsulfanyl]pyrimidines and... | 
				    			
				    				
				    					| 2024 | Invention | Fractalkine receptor antagonists for use in the prevention of thrombus formation and/or growth. T... | 
				    			
				    				
				    					|  | Invention | New use. 
There is provided herein a compound of formula I, or pharmaceutically acceptable salt t... | 
				    			
				    				
				    					| 2023 | Invention | Process for the stereoselective preparation of chiral 2-[(hetero) arylalkylsulfanyl]pyrimidines a... | 
				    			
				    				
				    					| 2022 | Invention | Process for the stereoselective preparation of chiral 2-[(hetero)arylalkylsulfanyl]pyrimidines an... | 
				    			
				    				
				    					| 2021 | Invention | N-hydroxycarboxamide derivatives useful as inhibitors of mammalian histone deacetylase activity. ... | 
				    			
				    				
				    					|  | Invention | Phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines and their use ... | 
				    			
				    				
				    					|  | Invention | New treatments of viral infections. There is provided a compound of formula (I), wherein R1,R2, Q... | 
				    			
				    				
				    					|  | Invention | 2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase... | 
				    			
				    				
				    					| 2019 | Invention | Process for the steroselective preparation of chiral 2- [(hetero)arylalkylsulfanyl] pyrimidines a... | 
				    			
				    				
				    					|  | Invention | A process for the stereoselective preparation of chiral 2-[(hetero)arylalkylsulfanyl]pyrimidines ... | 
				    			
				    				
				    					| 2016 | Invention | Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity. A compo... | 
				    			
				    				
				    					|  | Invention | Bisarylsulfonamides useful in the treatment of inflammation and cancer. A compound of formula (I)... | 
				    			
				    				
				    					|  | Invention | 2-phenyl-3h-imidazo[4,5-b]pyridine derivates useful as inhibitors of mammalian tyrosine kinase ro... | 
				    			
				    				
				    					| 2015 | Invention | Benzimidazole derivates useful as inhibitors of mammalian histone deacetylase activity. A compoun... | 
				    			
				    				
				    					| 2011 | Invention | Antibodies against ror1 and uses thereof. The invention relates to antibodies for inducing cell d... | 
				    			
				    				
				    					|  | Invention | Sulfonamide compounds. A compound of formula (I), wherein A is S, O or a double bond, and L is a ... | 
				    			
				    				
				    					|  | Invention | Bisarylsulfonamides useful as kinase inhibitors in the treatment of inflammation and cancer. A co... | 
				    			
				    				
				    					|  | P/S | Medicines for dental purposes; medicines for human purposes;
 medicines for veterinary purposes; ... | 
				    			
				    				
				    					| 2010 | Invention | 5,7-disubstituted thiazolo[4,5-d]pyrimidines as chemokine inhibitors. 3CR1 receptor antagonists a... | 
				    			
				    				
				    					|  | Invention | Biological inhibitors of ror1 capable of inducing cell death. The invention relates to antibodies... | 
				    			
				    				
				    					| 2007 | Invention | 5,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptors.... |